Let me be the fly in the ointment.
- The learning business part of JAN is not focus for them anymore and will need to get get rid of it as it is a commodity business.
- The split of $15 million cap raise will be spent 3 x 5 million. Seems rather neat and may not be based on any detailed planning.
- JAN is moving into the next phase of growth and may take of thier eyes of product and market development. There are risks as it moves from a owner led product company to a more corporate style hobnobbing with financiers
- JAN has competition in assessment with deep pockets.
While I am confident of JANs future I wont be putting on rose coloured glasses.
Let me be the fly in the ointment.- The learning business part...
Add JAN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $51.97M | |||
| Open | High | Low | Value | Volume |
| 19.5¢ | 20.0¢ | 19.3¢ | $25.27K | 128.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 995 | 20.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.0¢ | 7519 | 3 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| JAN (ASX) Chart |